CAS 5435-31-4
:1H-benzimidazole-2-sulfonamide
Description:
1H-benzimidazole-2-sulfonamide, with the CAS number 5435-31-4, is a chemical compound that features a benzimidazole core substituted with a sulfonamide group. This compound typically exhibits properties characteristic of both the benzimidazole and sulfonamide functional groups, including potential biological activity. Benzimidazoles are known for their role in various pharmacological applications, often acting as anti-parasitic, anti-fungal, or anti-cancer agents. The sulfonamide moiety contributes to its solubility in polar solvents and can enhance its interaction with biological targets. The compound is generally a solid at room temperature and may exhibit moderate stability under standard conditions. Its reactivity can be influenced by the presence of the sulfonamide group, which can participate in hydrogen bonding and other interactions. Overall, 1H-benzimidazole-2-sulfonamide is of interest in medicinal chemistry and may serve as a scaffold for the development of new therapeutic agents.
Formula:C7H7N3O2S
InChI:InChI=1/C7H7N3O2S/c8-13(11,12)7-9-5-3-1-2-4-6(5)10-7/h1-4H,(H,9,10)(H2,8,11,12)
SMILES:c1ccc2c(c1)nc([nH]2)S(=O)(=O)N
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 2 products.
1H-Benzo[d]imidazole-2-sulfonamide
CAS:1H-Benzo[d]imidazole-2-sulfonamide is a transcriptional regulator that is used in the treatment of bowel disease. It has been shown to be active against autoimmune diseases, such as inflammatory bowel disease and rheumatoid arthritis. 1H-Benzo[d]imidazole-2-sulfonamide regulates gene expression by binding to response elements in the promoter region of certain genes. The drug is an inhibitor of human serum proteases, which may lead to decreased inflammation and improved symptoms of inflammation bowel disease. The drug also has pharmacokinetic properties that make it suitable for oral administration.
Formula:C7H7N3O2SPurity:Min. 95%Molecular weight:197.21 g/molRef: 3D-FAA43531
Discontinued product

